13th September, 2012: According to researchers, a low priced drug that is generally used as a pain killer, can also kill drug-resistant TB (tuberculosis). The researchers of Weill Cornell Medical College point to a possible new therapy for people whose tuberculosis has turned immune to standard drug treatments.
Their primary worry is that oxyphenbutazone, the effective drug might never be tested in tuberculosis clinical trials. Weill Cornell Medical College’s Carl Nathan and team detected what they called as the totally “surprising” ability of oxyphenbutazone to shoot down drug-resistant tuberculosis after testing many approved drugs against it.
Nathan tells that this might help save lives if there was a way to test it in tuberculosis patients. Oxyphenbutazone is generally known by Tandearil, its trademark name. In early 1950s, this drug was introduced in the market as a registered drug for arthritis kind of pain, but lost its dominance in the market by 1970s.
Nathan also added that it is quite hard to start clinical studies on a medication which is so outdated in US, that is generally used here in veterinary medicine to ease pain.